Home » COMPETITIVE TECHNOLOGIES LICENSES HOMOCYSTEINE ASSAY TO ORTHO-CLINICAL DIAGNOSTICS
COMPETITIVE TECHNOLOGIES LICENSES HOMOCYSTEINE ASSAY TO ORTHO-CLINICAL DIAGNOSTICS
Competitive Technologies, Inc. (AMEX: CTT) and Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, announced today that a homocysteine assay license has been granted to Ortho-Clinical under CTT's U.S. Patent Number 4,940,658 and its foreign counterparts relating to homocysteine medical tests. Pursuant to the license, Ortho-Clinical will pay CTT an initial, upfront license fee and a per test royalty on sales of homocysteine assay products.
ArriveNet (http://press.arrivenet.com/pro/article.php/677741.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May